GEN3h
StockWatch: Bluebird Bio Plunges on Buyout, as Gene Therapy’s Woes Grow
Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...
Daily Maverick10h
Lessons from Siya and Footey — an insightful peek into the tough world of leadership in rugby
Performance coach Tom Dawson-Squibb is well known in rugby circles for his unique approach to leadership. In his entertaining book co-written with Nic Rosslee, Humanball: A Leadership Journey in South ...
Daily Maverick15h
Lessons from Siya and Footey — an insightful peek into the world of SA rugby’s stellar leadership
Performance coach Tom Dawson-Squibb is well known in rugby circles for his unique approach to leadership. In his entertaining book co-written with Nic Rosslee, Humanball: A Leadership Journey in South ...
Research Analysts Issue Forecasts for BMY Q1 Earnings
William Blair reduced their Q1 2026 EPS estimates for Bristol-Myers Squibb in a research report issued to clients and ...